Common vaccines may help protect the aging brain. Recent studies found that shingles and RSV vaccines could lower dementia risk. A new study offers even stronger evidence supporting shingles vaccine dementia protection. These findings suggest that vaccines may offer a promising path for preventing the disease.

What Makes the Recent Findings Significant?

Research in NPJ Vaccines examined Shingrix and Arexvy, two vaccines that protect against shingles and RSV. The study found that both vaccines may also help reduce dementia risk. The researchers traced these protective effects to an immune-boosting adjuvant called AS01.

The study reported strong benefits for vaccinated people. Those who received the shingles vaccine showed an 18% lower dementia risk. The researchers believe AS01 plays a key role in strengthening immune memory. This connection may help protect the brain during aging.

However, the researchers noted major study limitations. People who choose vaccines are often healthier overall than those who decline. They may eat better diets and engage in more physical activity. These lifestyle factors strongly influence dementia risk, but rarely show up in medical records.

These hidden factors can create important confounding variables. They can make vaccines appear more protective than they actually are. Researchers needed a way to separate vaccine effects from everyday habits. That required a study design closer to a randomized controlled trial.

[Read more…]

A Washington State resident has died from H5N5 bird flu. This case marks the world’s first death from this rare strain and the first recorded human infection. Officials say the event highlights a new chapter in global bird flu surveillance.

The patient was older and had underlying health conditions. They had been hospitalized for an extended period before death, and state officials provided no further identifying details. Investigators are still reviewing the patient’s medical and exposure history.

The CDC confirmed the H5N5 infection and continues to classify the public risk as low. Officials say that no additional people have tested positive for bird flu. They also report no evidence of human-to-human transmission at this time.

Investigators say the patient was exposed by a backyard flock with mixed domestic bird species. Exposure to infected birds remains the most common source of transmission. Officials are monitoring nearby flocks to ensure no further spread occurs.

[Read more…]

Recent research shows that preventing RSV in newborns can prevent asthma. RSV infection early in life can raise long-term asthma risk. The effect is strongest in children with genetic allergy risks. Early RSV infections also push the immune system to overreact to allergens.

Newborns who receive preventative RSV medication develop asthma less often. These findings show another benefit of early RSV protection. They also highlight the importance of inoculating young children. Protecting newborns may reduce severe asthma across communities.

Researchers from Belgium and Denmark conducted this large study together. Teams from V.I.P. and Ghent University collaborated with Danish scientists. They published their results in Science Immunology. Their work addresses a major health burden.

Asthma affects 5–15% of European children today. This long-term illness harms daily well-being and family life. It also creates heavy financial strain for health systems. These challenges have pushed experts to pursue new prevention strategies.

[Read more…]

Vaccination has reduced measles deaths by 88% from 2000 to 2024. The World Health Organization (WHO) says almost 59 million lives were saved by the vaccine. Still, measles killed about 95,000 people in 2024. Most deaths occurred in children younger than five years old.

The 2024 statistic shows one of the lowest annual death totals since 2000. Yet every preventable death reflects a major global failure. This is especially tragic when a cheap and effective vaccine exists. Lower deaths also do not erase the reality of rising global measles cases.

Measles caused about 11 million infections in 2024. This number exceeds 2019 pre-pandemic records by almost 800,000 cases. The WHO’s Director-General, Dr. Tedros Adhanom Ghebreyesus, called measles the most contagious virus. He warned that any weakness in global defenses can be exploited quickly.

[Read more…]

A man joined his wife and children for a camping trip in summer 2024. The airline pilot and his family ate a late dinner at 10 p.m. They enjoyed beef steaks, even though the family usually consumed chicken. The night seemed normal until early morning.

The man woke at 2 a.m. with sudden and severe stomach pain. He writhed in bed while vomiting and having diarrhea. A few hours later, he felt better and slept through the night. He and his wife considered seeking medical advice but did not understand what happened.

Two weeks later, the man was back home in New Jersey. He and his wife attended a barbecue that afternoon. The man ate a hamburger at 3 p.m. and later mowed the lawn with no issues. His symptoms began at 7:20 p.m., and by 7:37 p.m., his son had called emergency services, but the man died three hours later.

His autopsy was inconclusive, but his wife sought definitive answers. She contacted her friend, Dr. Aaron McFeely, who reviewed the report and contacted Virginia researchers. Blood tests confirmed that the man had alpha-gal syndrome from a lone star tick bite, marking the first confirmed fatal transmission of this allergy. Researchers say this case shows why broader awareness of alpha-gal risks is urgently needed.

[Read more…]